Glow TB4, BPC-157 and GHK-Cu blend for skin and regeneration research
Early findings from a small recent clinical trial run by the University of North Carolina at Chapel Hill showed that low weekly doses of semaglutide, the active ingredient in Ozempic and Wegovy, both made by Novo Nordisk, reduced alcohol consumption over two months in volunteers with alcohol use disorder
Coverage is expanding despite GLP-1s being the top cost concern
The rates of several cardiovascular and metabolic risk factors, such as blood pressure, heart rate, low density lipoprotein, and triglycerides were slightly lower in the intervention group than in the placebo group
Porter et al, 2018
It is marketed as a nasal spray (0.1% and 1% solutions) for the treatment of cognitive disorders, ischemic strokes, and optic nerve neuropathies